TAO Synergies TAOX
NASDAQ TAOX
$4.07 +0.06 (+1.50%)
As of: Sep 9, 2026 · 11:20 AM EDT

TAO Synergies (TAOX) Shares Outstanding (2019 - 2026)

TAO Synergies' (TAOX) quarterly Shares Outstanding (Entity) came in at $7.5 million in Q2 2026, up 377.45% on a YoY basis from $1.6 million in Q2 2025, and little changed quarter-over-quarter from $7.5 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Shares Outstanding (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Shares Outstanding (Entity) for 8 consecutive years, with $7.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 377.45% year-over-year to $7.5 million; the trailing twelve-month figure through Jun 2026 stood at $7.5 million (up 377.45% YoY), and the FY2025 full-year result was $3.3 million, up 143.17% from the prior year.
  • Shares Outstanding (Entity) steadied at $7.5 million in Q2 2026 per TAOX's latest filing, from $7.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $11.7 million in Q4 2023 and bottomed at $1.1 million in Q1 2024.
  • Historically, Shares Outstanding (Entity) has averaged $5.2 million across 5 years, with a median of $6.8 million in 2022.
  • The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) plunged 88.35% in 2024, then surged 437.62% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $7.3 million in 2022, then surged by 60.34% to $11.7 million in 2023, then slumped by 88.35% to $1.4 million in 2024, then jumped by 143.17% to $3.3 million in 2025, then jumped by 126.44% to $7.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $7.5 million, $7.5 million, and $3.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 212.35 Bn 198.36 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 181.19 Bn 178.01 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 132.48 Bn 124.62 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 82.59 Bn 74.60 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 61.45 Bn 56.27 Bn 1.37 Bn 61.30 Mn
6 Moderna 54.89 Bn 49.75 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 34.21 Bn 30.90 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.38 Bn 30.10 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 29.81 Bn 29.81 Bn 1.16 Mn 720.78 Mn
10 TAO Synergies 30.41 Mn 30.41 Mn - 7.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.47 Mn
Mar 31, 2026 7.48 Mn
Dec 31, 2025 3.30 Mn
Sep 30, 2025 2.55 Mn
Jun 30, 2025 1.57 Mn
Mar 31, 2025 1.39 Mn
Dec 31, 2024 1.23 Mn
Sep 30, 2024 1.32 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 1.04 Mn
Dec 31, 2023 11.65 Mn
Sep 30, 2023 10.70 Mn
Jun 30, 2023 7.36 Mn
Mar 31, 2023 7.50 Mn
Dec 31, 2022 6.99 Mn
Sep 30, 2022 6.99 Mn
Jun 30, 2022 6.96 Mn
Mar 31, 2022 6.94 Mn
Dec 31, 2021 5.02 Mn
Sep 30, 2021 6.20 Mn